Search results for: 'china cell ad give therapy industry development waste ppe'

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

The World Bank estimates that rapid population growth and urbanization have resulted in a global average waste generation of about 0.79 kilograms per citizen per day as of 2022. It predicts a direct relationship between waste generation and income levels and projects the daily per capita waste generation in high-income countries to increase by 19.0...

Food waste management has gained increased emphasis in recent times, especially in the context of the recently adopted United Nations Sustainable Development Goals. The initiative is driven mainly by the need to address declining natural resources, to reduce greenhouse gas emissions, and to reduce waste disposal into landfills. The current study gi...

Waste-to-energy (WtE) conversion is gaining strategic relevance as global waste generation accelerates and environmental regulations tighten. Municipalities and industries are facing mounting pressure to reduce landfill dependence, curb methane emissions, and secure reliable low-carbon energy sources. In this context, WtE is evolving from a seconda...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

Personal protective equipment (PPE) has become the main talking point due to the COVID-19 pandemic, as the pandemic radically shifted the focus of PPE's manufacturing, procuring, and use. Today, as the PPE industry struggles with pricing pressures, growing inflation, and global economic uncertainties, winners will offer strategic product differe...

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...